KLK3 and metastatic neoplasm: Secondly, the dogma of metastatic disease being incurable is challenged with our data as 15.7% (n = 30) had an undetectable PSA with a recovered testosterone (>50 ng/dL) level at last visit with a median follow-up of 46 months (IQR 32–71 months).